Plenful has secured $50 million in Series B funding, led by Dahner Corporation's Mitchell Rales and Arena Holdings, for product development and go-to-market acceleration.
Plenful has secured $50 million in Series B funding, led by Dahner Corporation's Mitchell Rales and Arena Holdings, for product development and go-to-market acceleration.
05/01/25, 3:11 PM
Location
san franciscoMoney raised
$50 million
Industry
health care
software
Round Type
series b
Investors
Susa/Kivu Ventures, Notable Capital, Tq Ventures, Bessemer Venture Partners, Arena Holdings, Mitchell Rales, Dahner Corporation
Plenful, a workflow-automation platform for pharmacy and healthcare operations, has secured $50 million in Series B funding. This funding brings its total raise to $76 million. The funds will be used for product development and to speed up its go-to-market efforts. The round was co-led by Mitchell Rales and Arena Holdings, with participation from several other investors.
Company Info
Location
san francisco, california, united states
Additional Info
Plenful is the leading AI workflow automation platform transforming how healthcare teams work. Built to empower healthcare operators and the patients they serve, Plenful enables healthcare organizations to scale operations with speed, precision, and intelligence. By combining deep human expertise with purpose-built AI, Plenful automates complex workflows to eliminate inefficiencies, enhance compliance, and unlock critical revenue. Trusted by top pharmacies, health systems, providers, and payors, Plenful powers smarter, faster, and more affordable healthcare operations.